RVD-Hpα TFA |
Katalog-Nr.GC66413 |
RVD-Hpα TFA ist die N-terminal verlÄngerte Form von menschlichem HÄmopressin, das als selektiver CB1-Rezeptoragonist wirkt. RVD-Hpα TFA erhÖht die intrazellulÄren Ca2+-Spiegel in Zellen, die CB1-Rezeptoren in vitro exprimieren. RVD-Hpα TFA auch hochaffiner CB2-positiver allosterischer Modulator (Ki = 50 nM).
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM).
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *